Tumor biomarkers predict clinical outcome of COVID-19 patients - 06/08/20
Doi : 10.1016/j.jinf.2020.05.069
Bangshun He a, b, #, Aifang Zhong c, f, #, Qiuyue Wu a, #, Xiong Liu d, g, #, Jie Lin e, f, Chao Chen c, Yiming He c, Yanju Guo a, Man Zhang a, Peiran Zhu a, Jian Wu a, Changjun Wang d, g, ⁎ 
, Shukui Wang b, ⁎ , Xinyi Xia a, f, g, ⁎
, Shukui Wang b, ⁎ , Xinyi Xia a, f, g, ⁎ a COVID-19 Research Center, Institute of Laboratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, 210002, China
b General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210006, China
c Medical Technical Support Division, Changzhou Medical District, the 904th Hospital, Changzhou, Jiangsu, 213003, China
d Center for Disease Control and Prevention of PLA, Beijing, 100071, China
e Department of Disease Control and Prevention, the 904th Hospital, Wuxi, Jiangsu, 214000, China
f Department of Laboratory Medicine & Blood Transfusion, Wuhan Huoshenshan Hospital, Wuhan, Hubei, 430100, China
g Joint Expert Group for COVID-19, Wuhan Huoshenshan Hospital, Wuhan, Hubei, 430100, China
⁎Corresponding author: X. Xia, Institute of Laboratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, 210002, China.Institute of Laboratory MedicineJinling HospitalNanjing University School of MedicineNanjingJiangsu210002China⁎⁎Corresponding author: S. Wang, General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210006, China.General Clinical Research CenterNanjing First HospitalNanjing Medical UniversityNanjingJiangsu210006China⁎⁎⁎Corresponding author: C. Wang, Center for Disease Control and Prevention of PLA, Beijing, 100071, China.Center for Disease Control and Prevention of PLABeijing100071China
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
© 2020
Elsevier Ltd. Tous droits réservés.
Vol 81 - N° 3
P. 452-482 - septembre 2020 Retour au numéro
Article précédent
- SARS-CoV-2 RNA detection in tears and conjunctival secretions of COVID-19 patients with conjunctivitis
- Noemi Güemes-Villahoz, Barbara Burgos-Blasco, Ana Arribi-Vilela, Pedro Arriola-Villalobos, Beatriz Vidal-Villegas, Rosalia Mendez-Fernandez, Alberto Delgado-Iribarren, Julian Garcia-Feijoo
- Interleukin-6 as prognosticator in patients with COVID-19
- Elisa Grifoni, Alice Valoriani, Francesco Cei, Roberta Lamanna, Anna Maria Grazia Gelli, Benedetta Ciambotti, Vieri Vannucchi, Federico Moroni, Lorenzo Pelagatti, Roberto Tarquini, Giancarlo Landini, Simone Vanni, Luca Masotti
Bienvenue sur EM-consulte, la référence des professionnels de santé.